TY - JOUR
T1 - Analysis of antigens targeted by circulating IgG and IgA autoantibodies in 50 patients with cicatricial pemphigoid
AU - Murakami, Hector
AU - Nishioka, Shoji
AU - Setterfield, Jane
AU - Bhogal, Balbir S.
AU - Black, Martin M.
AU - Zillikens, Detlef
AU - Yancey, Kim B.
AU - Balding, Shawn D.
AU - Giudice, George J.
AU - Diaz, Luis A.
AU - Nishikawa, Takeji
AU - Kiyokawa, Chie
AU - Hashimoto, Takashi
N1 - Funding Information:
We thank all the dermatologists who kindly provided us with CP sera used in this study. We also thank Ms M. Makino for technical assistance. This work was supported in part by Grant-in-Aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (No. 04454289), Monbusho International Scientific Collaborative Research program (No. 02044130), a grant from the Ministry of Health and Welfare of Japan, a collaborative research grant from the British Council, Tokyo, Japan, US Public Health Service Grants Ro1-AR32599, Ro1-AR32081, Ro1-AR40410 and a Veterans Affairs Merit Review Grant. Dr H. Murakami is supported by a Grant from the Japan International Cooperation Agency (JICA). Dr S.D. Balding has been supported by training grant T32-AR07577 from the National Institutes of Health.
PY - 1998/5
Y1 - 1998/5
N2 - In this study we investigated sera from 50 typical cicatricial pemphigoid (cP) patients. By indirect immunofluorescence on 1 M NaCl-split human skin sections, IgG of 17 sera and IgA of 22 sera reacted with the epidermal side of the split, while IgG of two sera reacted with the dermal side. These latter two sera were later confirmed to be anti-epiligrin CP. By immunoblotting of epidermal extracts, IgG of 14 sera reacted with the 230 kD bullous pemphigoid (BP) antigen (BP230). IgG of 15 sera and IgA of 11 sera reacted with the 180 kD BP antigen (BP180). Interestingly, a bacterial fusion protein containing the BP180 NC16a domain was recognized by IgG of 18 sera but not by IgA of any sera. Fusion proteins containing the C-terminal region of BP180 were recognized by IgG of 20 sera, but it was detected by IgA of only two sera. Our results suggest that, although CP sera show very low titers of autoantibodies, a considerable number of sera contain IgG antibodies to BP180 (either NCl6a or C-terminal domain), confirming previous studies. In addition, we showed that greater numbers of IgA antibodies react with BP180, seemingly with different types of epitopes from those for IgG antibodies. Because the specificity of IgG antibodies is not very different from those in BP, IgA antibodies may play a specific role for the development of characteristic clinical features in CP. Future studies should elucidate the pathogenic role of the IgA antibodies in CP.
AB - In this study we investigated sera from 50 typical cicatricial pemphigoid (cP) patients. By indirect immunofluorescence on 1 M NaCl-split human skin sections, IgG of 17 sera and IgA of 22 sera reacted with the epidermal side of the split, while IgG of two sera reacted with the dermal side. These latter two sera were later confirmed to be anti-epiligrin CP. By immunoblotting of epidermal extracts, IgG of 14 sera reacted with the 230 kD bullous pemphigoid (BP) antigen (BP230). IgG of 15 sera and IgA of 11 sera reacted with the 180 kD BP antigen (BP180). Interestingly, a bacterial fusion protein containing the BP180 NC16a domain was recognized by IgG of 18 sera but not by IgA of any sera. Fusion proteins containing the C-terminal region of BP180 were recognized by IgG of 20 sera, but it was detected by IgA of only two sera. Our results suggest that, although CP sera show very low titers of autoantibodies, a considerable number of sera contain IgG antibodies to BP180 (either NCl6a or C-terminal domain), confirming previous studies. In addition, we showed that greater numbers of IgA antibodies react with BP180, seemingly with different types of epitopes from those for IgG antibodies. Because the specificity of IgG antibodies is not very different from those in BP, IgA antibodies may play a specific role for the development of characteristic clinical features in CP. Future studies should elucidate the pathogenic role of the IgA antibodies in CP.
UR - http://www.scopus.com/inward/record.url?scp=18144438536&partnerID=8YFLogxK
U2 - 10.1016/S0923-1811(97)00067-4
DO - 10.1016/S0923-1811(97)00067-4
M3 - Journal articles
C2 - 9651827
AN - SCOPUS:18144438536
SN - 0923-1811
VL - 17
SP - 39
EP - 44
JO - Journal of Dermatological Science
JF - Journal of Dermatological Science
IS - 1
ER -